ISSN: 2161-1149 (Printed)
Tatiana Melo Fernandes1, Karina Martins-Cardoso2, Franciele Cristina Ferreira Pereira1, Nathalie Henriques Silva Canedo1, Bartira Souza Melo1 , Leila Chimelli5, Walter Carlos de Oliveira Bohrer1, Mariana D’Oliveira Bulhões da Costa1, Carlos de Oliveira Nascimento1, Maressa Barbosa Beloni Lirio1, Eduardo Siqueira2, Gutemberg Gomes Alves3, Shana Priscila Coutinho Barroso2, Dirlei Nico4*
COVID-19-related pain and muscular weakness have been documented often in more severe instances and in post- mortem biopsies. Patients infected with the severe acute respiratory syndrome virus (SARS-CoV-2) have also suffered neurological damages. Furthermore, during and after an infection, immune-mediated necrotizing myopathy might develop. SARS-CoV-2 infection has also been linked to immune-mediated necrotizing myopathy in case reports. In this report, a young patient with minimal comorbidities was brought to the hospital with seronegative immune- mediated necrotizing myopathy due to COVID-19.